ABSTRACT Human fibroblasts were subjected to nutritionally induced GI block, followed by release and subsequent entry into S phase, and exposed to nontoxic concentrations of carcinogens in early S phase. Cell transformation occurred as determined by early morphologic cell alterations, anchorage-independent colony formation, cell invasiveness, and augmentation of Ab 376 human malignancy-specific cell-surface antigenic determinant. Methylazoxymethanol acetate was the most potent transforming agent at doses that were negative in toxicity tests. Benzamide (10 FM intracellular concentration), a specific inhibitor of poly(ADPribose) polymerase, prevented transformation in a cell cycle-specific manner, maximal prevention coinciding with early S phase, also characteristic of maximal susceptibility to transformation. Neither an interference of carcinogen deoxyguanosine nucleoside adduct formation nor a chemical reaction between benzamide and carcinogens was detected. Methylazoxymethanol acetate at transforming but nontoxic dose partially inhibited poly(ADP-ribosyl)ation to about the same extent as benzamide. However, simultaneous exposure of cells to both agents in early S phase, resulting in the prevention of transformation, augmented poly(ADPribosyl)ation above the controls. Enzymatic activities ran parallel with the formation of DNA-associating polymer-nonhistone protein adducts that are assumed to regulate the physiological function of chromatin at the structural level.
A significant increase in poly(ADP-ribosyl)ation of nonhistone proteins was found in an early precancerous state of hamster liver (1) and in regenerating rat liver (2) , suggesting that cellular regeneration may be a common reason for the accelerated enzymatic rates. Cellular regeneration is known to augment the number of cells in S phase and this has been correlated with the facilitation of neoplastic transformation in organs (3) and in cultured C3H/101/3 CL8 mouse fibroblasts (4) . Poly(ADP-ribosyl)ation also exhibits a cell cycle-dependent oscillation, a maximum coinciding with S phase after a release of G1 block (5) . These observations tend to suggest an as yet undefined connection between (poly ADP-ribosyl)ation, cell cycle, and neoplastic transformation.
Ontogenic development (6) , the effect of developmental hormones (7) (8) (9) , and differentiation (10) also coincide with changes in rates of poly(ADP-ribosyl)ation of mainly nonhistone proteins (11, 12) that are thought to regulate selective gene expression (13) . Identification of poly(ADP-ribose) as a unique nucleic acid (14, 15) that is covalently bound to presumably DNA-associated proteins may provide a molecular model of chromatin regulation. Ionic environment-dependent helical polymer chains of poly(ADP-ribose) (15) may act as crosslinking agents between regulatory proteins and, depending on their nature and localization, could alter chromatin conformations, expressed as karyological changes that accompany the cell cycle in normal and malignant cells (16, 17) . The poly(ADP-ribosyl)ation-dependent variation in nucleosomal structures (18) tends to support the proposed regulatory mechanism.
We examined the possible participation of poly(ADP-ribosyl)ation of chromatin proteins in carcinogen-induced oncogenic transformation of synchronized human fibroblasts (19) (20) (21) . This model was chosen because we intended to obtain information that could be relevant to human neoplasia. If poly(ADPribosyl)ation of certain chromatin proteins in the S phase plays a role in the regulation of carcinogen-induced oncogenic transformation, then a selective inhibitor of poly(ADP-ribose) polymerase, benzamide (22) , would be expected to alter transformation. A preliminary report has appeared (23) .
MATERIALS AND METHODS
Cells and Culture Conditions for G1 Block/Release. Primary human fibroblasts were prepared (24) and cultured as reported (25) . These cells have a finite replicative capacity of 35 + 7 population doublings, which is 22.4 hr, plating efficiency between 95 and 100%, and relative colony (defined as 50 cells)-forming efficiency of 20-21%. For each series of experiments the average yield of cells prior to the soft-agar growth test was 3 x 10r ± 20% per flask (75 cm2 each) and for biochemical studies the number of cells was scaled up to about 20 X 106. G1 block (26) was induced as described (19) . It is critical that the number of population doublings at the initiation of G1 block must not exceed 5 and the doubling time 23 hr; otherwise resistance to transformation by carcinogens may develop (24) and the variations in poly(ADP-ribosyl)ation will differ from results reported here. In G1 block (19) radiolabeling.fell to 0.1% of controls within 24 hr. The G1 block was released by refeeding with the minimal essential medium, which also contained 0.5 unit of insulin per ml (see Fig. 4 ). After two washings with minimal essential growth medium, from which bovine serum was deleted, cultures were divided (1:2) and culturing commenced after the addition of 2x concentrated essential vitamins, 9x concentrated essential amino acids, 0.2% NaHCO3, 50 ag of gentocin per ml, and 20% fetal serum until confluence was approached and serial passages were continued (1:10) in the enriched minimal essential medium (see Fig. 4 ). Seeding (4 X The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Proc. Natl. Acad. Sci. USA 80(1983) metabolically induced G1/S block (Fig. 4) and exposure lasted 10 hr, followed by three washings and refeeding with fresh media (25 (Fig. 4) this was only 10 hr, providing an extra margin of safety for the determination of nontoxic doses, which were further tested by the absence of effects on plating efficiency and doubling time.
Criteria for Phenotypic Transformation. In addition to colony counts on soft agar (19, 25) , criteria for phenotypic transformation were cellular invasiveness (27) (19) was identical with the incidence of tumor formation by surgically obtained human fibrosarcomas, cultured parallel with transformed fibroblasts, and the low incidence (20-30%) is probably explained by genetic differences between the human cells and the host (30) .
Biochemical Procedures. Biochemical procedures related to poly(ADP-ribose) were the same as published ( Evidence of Cellular Transformation. The characteristic morphology of fibroblasts (Fig. 1, group 1 ) was markedly altered when cell cultures were exposed to RFC1 doses of carcinogens after five cell doublings. Benzamide in cell cultures inhibited this phenotypic change (Fig. 1, group 3 ), whereas the cell morphology shown in Fig. 1 (33) . The quantities of these major and also of 7220 Cell Biology: Kun et or benzamide-treated cells when drugs were added separately or in combination (5.26 x 108 daltons). At RCF1 (7 AM) methylazoxymethanol acetate induced an alkali instability in DNA size, as evident from the appearance of a second DNA molecular species of 1.52 x 10' daltons. However, prevention of transformation by benzamide did not coincide with reassociation to the larger size DNA; thus, no connection between apparent fragmentation and reassociation could be ascertained that correlated with transformation and its prevention.
Variations of Poly(ADP-ribose) Polymerase Activity and Determination of Products. After 10 hr of exposure to 1 mM benzamide in cell cultures, inhibition of enzymatic activity was similar to that observed in permeabilized cells at 10 AM benzamide. As shown in Fig. 5 (Table 1 , carcinogen 1) inhibited poly(ADP-ribose) polymerase activity in S phase nearly to the same extent as 10 ,uM benzamide, but combined exposure of cells in the S phase (see Fig. 4 ) to both the carcinogen and benzamide-resulting in the inhibition of transformation (Table 1) -not only restored rates to the level of controls in S phase but also augmented them. Biochemical studies (Table 2 and Fig. 5 ) were confined to these experimental conditions. As shown in Table 2 , after incubation of permeabilized cells for 20 or 40 min, protein adducts of short chains (phenol soluble) and long chains (H20 soluble) were isolated (40) , indicating that prolonged reaction resulted in the synthesis of predominantly long chain polymer-protein adducts. Our results indicate that in S phase and after exposure to methylazoxymethanol acetate and benzamide both initiation ,and elongation rates increased simultaneously, consistent with an augmentation of the polymerase. 1000 . BA+ MAMA Table 2 and Fig. 4) (14, 15) , it may be assumed that a structural regulation of physiological chromatin function in S phase has been reestablished by the augmentation of certain DNA-associated poly(ADP-ribose)-nonhistone-protein adducts and this process may be causally related to the prevention of transformation. A chromatin structure-dependent control of gene regulation has been proposed earlier (43) , although molecular mechanisms involved were not identified. Currently held mechanisms of neoplastic transformation by oncogene expression (44) (45) (46) , gene translocations, and amplifications (47, 48) may be extended by the poly(ADPribosyl)ation-dependent supramolecular control of availability of DNA domains that could involve critical enhancing regions. It was shown that 3-aminobenzamide at high doses (300-600 mg/kg) if administered to rats, 4 hr after in vivo pretreatment with a hepatocarcinogen, appears to augment the development of premalignant liver foci, characterized by increased y-glutamyl transpeptidase (49) . An overwhelming dose of an inhibitor of poly(ADP-ribose) polymerase when administered in vivo is likely to serve primarily as an enzyme inhibitor of the polymerase and not as an inducer and therefore may reinforce carcinogenicity, especially if the carcinogen has been given prior to the inhibitor. It follows that specific pharmacokinetic and cellular kinetic conditions have to be observed to reproduce the antitransforming effect of nontoxic doses of inhibitors of poly-(ADP-ribose) polymerase in intact animals. A variety of inhibitors of poly(ADP-ribose) polymerase have been found to serve as antitransforming agents in fibroblast cultures if applied under conditions described here (unpublished data); therefore, the observed effect is not confined to benzamide.
